New Retina Radio
New Retina Radio

02.11.22

Exploring the clinical development program for an innovative, continuous delivery treatment for nAMD

Recently, the first refillable, intraocular device that enables continuous delivery of therapy was FDA approved for nAMD. John Kitchens, MD sits down with one of the investigators, Dante Pieramici, MD, to learn more about his experiences with the clinical development program and this innovative drug delivery system. This special episode of New Retina Radio is supported by Genentech USA, Inc., which is responsible for its content.

View full description +

MORE EPISODES

02.05.26

What I Wish I Knew: Insights From the Next Generation of Retina Specialists

Nemo Patel, MD; Sam Minaker, MD; and Has Al-khersan, MD

02.05.26

Practical Insights on Adopting FDA-Approved Treatments Into Practice

Nemo Patel, MD; Danny Mammo, MD; and Matthew Donovan, MD

02.05.26

The Race to Slow GA: A Retina Specialist in the Driver’s Seat of GA Treatment

Nemo Patel, MD and Patrick Staropoli, MD

01.15.26

New Retina Radio Journal Club w/ VBS: Diagnosis Delays in Stargardt Disease

Alexis Warren, MD; Jesse Sengillo, MD; and Sruthi Arepalli, MD

01.08.26

The Fellow Eye: Episode 1

David Fell MD; Justin Muste, MD; Flavius Beca, MD

12.18.25

New Retina Radio Journal Club w/ VBS: Assessing Surgical Competency Among Retina Fellows: Perspectives from Directors and Graduates

Nikisha Kothari, MD; Jesse Sengillo, MD; and Nicholas Farber, MD

12.09.25

DME, DR, and Next-Generation Therapies

David Miller, MD; Esther Kim, MD; and Ehsan Rahimy, MD

12.09.25

Wet AMD and Next-Generation Therapies

David Miller, MD; Esther Kim, MD; and Ehsan Rahimy, MD

Show More